Bio-Rad Laboratories
- Market cap
- 9.84B
- P/E (TTM)i
- 44.81
- P/Bi
- 1.37
- EPSi
- 27.85
- Div yieldi
- 0.00%
- 52W posi
- 82%
Anonymous reader poll. Unscientific, not investment advice.
Bio-Rad Laboratories ended the session at 367.92, down 0.25%. Its market capitalisation is about 9.84B, the #1479 most valuable US-listed company we track. The 1 analysts covering the stock are, on balance, at Buy, targeting an average of 390.00 (+6%). Against a 52-week band of 236.73-396.23, the shares are currently 82% of the way up.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 week.
- Recent price momentum is +24.9% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 3.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 368.83
- Open
- 373.16
- Day range
- 363.98 - 374.60
- Avg price
- 370.06
- Volume
- 251.90K
- Turnover
- 93.22M
- Turnover ratei
- 1.18%
- Volume ratioi
- 1.09
- Amplitudei
- 2.88%
- 52-week rangei
- 236.73 - 396.23
Valuation
- P/Ei
- 13.21
- P/E (TTM)i
- 44.81
- P/Bi
- 1.37
- EPSi
- 27.85
- Book value / shi
- 268.30
- Net profit
- 744.66M
- Net assets
- 7.17B
Share structure
- Market cap
- 9.84B
- Float capi
- 7.86B
- Shares out
- 26.74M
- Float sharesi
- 21.35M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
7.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-10.47M net over the window
Short interest
- Shares short
- 998.65K
- % of floati
- 3.73%
- Days to coveri
- 3.83
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Bio-Rad Laboratories (BIO)?
Bio-Rad Laboratories last traded at 367.92. The quote on this page refreshes every few seconds while US markets are open.
What is Bio-Rad Laboratories's market cap?
About 9.84B.
What is the P/E ratio of Bio-Rad Laboratories?
The trailing twelve-month P/E is 44.81. The Valuation tab shows it against the stock's own five-year range.
Does Bio-Rad Laboratories pay a dividend?
Bio-Rad Laboratories does not currently pay a regular dividend.
Is Bio-Rad Laboratories a buy according to analysts?
The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 390.00, which implies 6.0% upside from the current price. This is not investment advice.
What is Bio-Rad Laboratories's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Bio-Rad Laboratories a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.